Alignment Healthcare Inc (ALHC)’s Market Momentum: Closing Strong at 10.88, Down -4.81

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $10.88, down -4.81% from its previous closing price of $11.43. In other words, the price has decreased by -$4.81 from its previous closing price. On the day, 1.22 million shares were traded. ALHC stock price reached its highest trading level at $11.73 during the session, while it also had its lowest trading level at $10.79.

Ratios:

To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.78 whereas as Long-Term Debt/Eq ratio is at 1.78.

On May 30, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7.75 to $11.

On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $10 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 15 ’24 when Maroney Dawn Christine sold 30,000 shares for $10.77 per share. The transaction valued at 323,082 led to the insider holds 1,726,097 shares of the business.

Freeman Robert Thomas sold 30,500 shares of ALHC for $350,872 on Oct 14 ’24. The Chief Financial Officer now owns 164,109 shares after completing the transaction at $11.50 per share. On Oct 14 ’24, another insider, FCO HOLDINGS LLC, who serves as the Officer of the company, bought 61,000 shares for $11.45 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2081344000 and an Enterprise Value of 1938649472. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.93 while its Price-to-Book (P/B) ratio in mrq is 16.82. Its current Enterprise Value per Revenue stands at 0.869 whereas that against EBITDA is -18.544.

Stock Price History:

Over the past 52 weeks, ALHC has reached a high of $12.36, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 5.93%, while the 200-Day Moving Average is calculated to be 40.72%.

Shares Statistics:

It appears that ALHC traded 1.22M shares on average per day over the past three months and 1168830 shares per day over the past ten days. A total of 188.95M shares are outstanding, with a floating share count of 86.93M. Insiders hold about 54.59% of the company’s shares, while institutions hold 41.05% stake in the company. Shares short for ALHC as of 1727654400 were 3911333 with a Short Ratio of 3.21, compared to 1724976000 on 4481593. Therefore, it implies a Short% of Shares Outstanding of 3911333 and a Short% of Float of 3.2.

Most Popular